China is determined to okay 600 million doses of a coronavirus vaccine by the end of 2020, Wang Junzhi, a member of the government's national vaccine research and development specialist group, claimed on Friday, APA reports citing Teletrader.
Last week, Sinopharm's subsidiary China National Biotec Group (CNBG) filed an emergency use application to Chinese regulators, seeking the approval of its COVID-19 vaccine candidate.
Previously, Sinovac executive Weining Meng unveiled the company is expected to announce final trial results of its vaccine called CoronaVac in December.